Cécile Emeraud

1.0k total citations
43 papers, 640 citations indexed

About

Cécile Emeraud is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry. According to data from OpenAlex, Cécile Emeraud has authored 43 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Medicine, 18 papers in Endocrinology and 10 papers in Clinical Biochemistry. Recurrent topics in Cécile Emeraud's work include Antibiotic Resistance in Bacteria (35 papers), Enterobacteriaceae and Cronobacter Research (13 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Cécile Emeraud is often cited by papers focused on Antibiotic Resistance in Bacteria (35 papers), Enterobacteriaceae and Cronobacter Research (13 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Cécile Emeraud collaborates with scholars based in France, United States and French Polynesia. Cécile Emeraud's co-authors include Laurent Dortet, Thierry Naas, Rémy A. Bonnin, Agnès B. Jousset, Delphine Girlich, Nicolas Fortineau, Saoussen Oueslati, L. Escaut, Athénaïs Boucly and Sandrine Bernabeu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Microbiology Reviews and Journal of Clinical Microbiology.

In The Last Decade

Cécile Emeraud

35 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Emeraud France 16 483 219 168 130 123 43 640
Yonggui Zheng China 9 518 1.1× 151 0.7× 197 1.2× 139 1.1× 136 1.1× 12 612
Robin Haag Germany 4 416 0.9× 161 0.7× 158 0.9× 131 1.0× 108 0.9× 7 562
Ya-Ting Chang Taiwan 7 404 0.8× 163 0.7× 158 0.9× 147 1.1× 93 0.8× 16 553
Kathy Fauntleroy United States 8 371 0.8× 125 0.6× 140 0.8× 74 0.6× 173 1.4× 13 475
Renru Han China 12 675 1.4× 210 1.0× 272 1.6× 125 1.0× 159 1.3× 39 764
Niels Pfennigwerth Germany 17 626 1.3× 250 1.1× 163 1.0× 150 1.2× 198 1.6× 47 692
Chaitra Shankar India 16 709 1.5× 269 1.2× 156 0.9× 117 0.9× 155 1.3× 42 826
Angela de Haan Netherlands 6 402 0.8× 193 0.9× 88 0.5× 72 0.6× 186 1.5× 11 467
Shio-Shin Jean Taiwan 9 359 0.7× 116 0.5× 144 0.9× 136 1.0× 70 0.6× 17 491
Marco Coppi Italy 15 342 0.7× 93 0.4× 154 0.9× 84 0.6× 89 0.7× 37 557

Countries citing papers authored by Cécile Emeraud

Since Specialization
Citations

This map shows the geographic impact of Cécile Emeraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Emeraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Emeraud more than expected).

Fields of papers citing papers by Cécile Emeraud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Emeraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Emeraud. The network helps show where Cécile Emeraud may publish in the future.

Co-authorship network of co-authors of Cécile Emeraud

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Emeraud. A scholar is included among the top collaborators of Cécile Emeraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Emeraud. Cécile Emeraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emeraud, Cécile, et al.. (2025). Comparative evaluation of disc diffusion and Liofilchem™ MTS strip methods with broth microdilution for cefepime/enmetazobactam susceptibility testing. Journal of Antimicrobial Chemotherapy. 80(5). 1220–1223. 1 indexed citations
2.
Emeraud, Cécile, et al.. (2025). Enhanced identification of Morganella spp. using MALDI-TOF mass spectrometry. PubMed. 37. 9–13.
5.
Robert, Manon, et al.. (2025). First report of SME-carbapenemase–producing Serratia marcescens in France. Journal of Antimicrobial Chemotherapy. 80(5). 1457–1461.
6.
Dortet, Laurent, A. Birer, Cécile Emeraud, et al.. (2025). Characterization of Carbapenemase-producing Enterobacterales isolated from patients returning from Sub-Saharan Africa, France, 2015–2022. Journal of Antimicrobial Chemotherapy. 80(8). 2285–2294.
7.
Girlich, Delphine, et al.. (2025). Emergence and Polyclonal Dissemination of blaNDM-7–Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021–2023. Emerging infectious diseases. 31(10). 1998–2002.
8.
Emeraud, Cécile, Delphine Girlich, Elodie Creton, et al.. (2024). Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France. Journal of Antimicrobial Chemotherapy. 79(3). 683–685. 4 indexed citations
9.
Emeraud, Cécile, Sandrine Bernabeu, Delphine Girlich, et al.. (2024). Oxacillinase-484–Producing Enterobacterales, France, 2018–2023. Emerging infectious diseases. 30(10). 2178–2182. 1 indexed citations
11.
Bonnin, Rémy A., Sandrine Bernabeu, Cécile Emeraud, et al.. (2023). In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics. 12(1). 102–102. 13 indexed citations
12.
Emeraud, Cécile, Sandrine Bernabeu, & Laurent Dortet. (2023). In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria. Antibiotics. 12(10). 1493–1493. 2 indexed citations
13.
Jousset, Agnès B., A. Birer, Isabelle Rosinski‐Chupin, et al.. (2023). Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France. Emerging infectious diseases. 29(9). 1877–1881. 12 indexed citations
14.
Bonnin, Rémy A., Sandrine Bernabeu, Cécile Emeraud, et al.. (2022). Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam. International Journal of Antimicrobial Agents. 60(4). 106660–106660. 18 indexed citations
15.
Bonnin, Rémy A., Cécile Emeraud, Agnès B. Jousset, Thierry Naas, & Laurent Dortet. (2022). Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales. Clinical Microbiology and Infection. 28(8). 1156.e1–1156.e5. 47 indexed citations
16.
Girlich, Delphine, Cécile Emeraud, Lauraine Gauthier, et al.. (2021). Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort study. The Lancet Microbe. 2(10). e536–e544. 36 indexed citations
17.
Bonnin, Rémy A., Delphine Girlich, Agnès B. Jousset, et al.. (2021). Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii. International Journal of Antimicrobial Agents. 57(3). 106285–106285. 7 indexed citations
18.
Bonnin, Rémy A., Agnès B. Jousset, Cécile Emeraud, et al.. (2021). Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales. Frontiers in Medicine. 7. 616490–616490. 54 indexed citations
19.
Emeraud, Cécile, Delphine Girlich, Agnès B. Jousset, et al.. (2020). Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?. Journal of Antimicrobial Chemotherapy. 75(8). 2120–2123. 18 indexed citations
20.
Emeraud, Cécile, Seher Yılmaz, Nicolas Fortineau, Gaëlle Cuzon, & Laurent Dortet. (2020). Quality indicators for blood culture: 1 year of monitoring with BacT/Alert Virtuo at a French hospital. Journal of Medical Microbiology. 70(3). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026